aid: cg-oncology

name: CG Oncology

image: https://cgoncology.com/wp-content/uploads/2025/12/OG_Homepage.jpg

description: 'CG Oncology is a publicly traded biotechnology company focused on developing bladder‑sparing immunotherapies for non‑muscle invasive bladder cancer. The firm leverages oncolytic viral platforms to create novel treatments, maintains an active pipeline, and provides extensive investor information through its corporate site. It engages clinicians, patients, and investors with detailed scientific, clinical, and financial resources.'

url: https://raw.githubusercontent.com/api-evangelist/cg-oncology/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-08 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-10-07'

modified: '2026-10-07'

tags:
- Oncology
- Bladder Cancer
- Immunotherapy
- Drug Development

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: Hosts
  url: hosts/cg-oncology-hosts.yml
- type: DomainSecurity
  url: security/cg-oncology-domain-security.yml
- type: Website
  url: https://cgoncology.com
- type: PrivacyPolicy
  url: https://cgoncology.com/privacy-policy/
- type: TermsOfService
  url: https://cgoncology.com/terms-of-service/
- type: InvestorRelations
  url: https://ir.cgoncology.com

apis: []

x-coverage:
  state: none
  reason: no-developer-program
  detail: The company provides no public developer program or API documentation.
  evidence:
    - url: https://cgoncology.com
      status: 200
  checked: '2026-10-08'
x-enrichment:
  date: '2026-10-08'
  status: enriched
  artifacts_added: 5
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local